0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Independent and joint associations of general and abdominal obesity with the risk of conventional adenomas and serrated polyps: A large population‐based study in East Asia

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Evidence regarding associations of general and abdominal obesity with the risk of conventional adenomas (ADs) and serrated polyps (SPs) from Asian population is scarce. Our study aimed to investigate the independent and joint associations of general obesity assessed by body mass index (BMI) and abdominal obesity assessed by waist circumference (WC) or waist‐to‐hip ratio (WHR) with the risk of ADs and SPs among 25 222 participants recruited by a population‐based screening program. Compared to participants with normal BMI, those with a BMI ≥28 kg/m 2 had increased risk of ADs (odds ratio [OR] 1.52, 95% confidence interval [CI]: 1.36‐1.70) and SPs (OR 1.69, 95% CI: 1.38‐2.07). For participants with a WC ≥102 cm (≥88 cm for females), the risk of ADs (OR 1.37, 95% CI: 1.25‐1.51) and SPs (OR 1.81, 95% CI: 1.52‐2.16) was higher than that of the reference group. For participants with a WHR ≥0.95 (≥0.90 for females), the risk of ADs (OR 1.26, 95% CI: 1.16‐1.36) and SPs (OR 1.46, 95% CI: 1.26‐1.69) was higher than that of the reference group. Moreover, participants with both BMI ≥28 kg/m 2 and WC ≥102 cm (≥88 cm for females) had 61% and 119% higher risk of ADs (OR 1.61, 95% CI: 1.39‐1.85) and SPs (OR 2.19, 95% CI: 1.70‐2.82) compared to those with both normal BMI and WC. These findings indicate that both general and abdominal obesity are associated with SPs and ADs, presenting stronger association with SPs than ADs. Moreover, the association is more evident when both obesities exist.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: found
          • Article: not found

          Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

          This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2-fold to 3-fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied <2-fold for men and little for women. Death rates for female breast and cervical cancers, however, were considerably higher in transitioning versus transitioned countries (15.0 vs 12.8 per 100,000 and 12.4 vs 5.2 per 100,000, respectively). The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with a larger increase in transitioning (64% to 95%) versus transitioned (32% to 56%) countries due to demographic changes, although this may be further exacerbated by increasing risk factors associated with globalization and a growing economy. Efforts to build a sustainable infrastructure for the dissemination of cancer prevention measures and provision of cancer care in transitioning countries is critical for global cancer control.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.

            (2004)
            A WHO expert consultation addressed the debate about interpretation of recommended body-mass index (BMI) cut-off points for determining overweight and obesity in Asian populations, and considered whether population-specific cut-off points for BMI are necessary. They reviewed scientific evidence that suggests that Asian populations have different associations between BMI, percentage of body fat, and health risks than do European populations. The consultation concluded that the proportion of Asian people with a high risk of type 2 diabetes and cardiovascular disease is substantial at BMIs lower than the existing WHO cut-off point for overweight (> or =25 kg/m2). However, available data do not necessarily indicate a clear BMI cut-off point for all Asians for overweight or obesity. The cut-off point for observed risk varies from 22 kg/m2 to 25 kg/m2 in different Asian populations; for high risk it varies from 26 kg/m2 to 31 kg/m2. No attempt was made, therefore, to redefine cut-off points for each population separately. The consultation also agreed that the WHO BMI cut-off points should be retained as international classifications. The consultation identified further potential public health action points (23.0, 27.5, 32.5, and 37.5 kg/m2) along the continuum of BMI, and proposed methods by which countries could make decisions about the definitions of increased risk for their population.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A genetic model for colorectal tumorigenesis

                Bookmark

                Author and article information

                Contributors
                Journal
                International Journal of Cancer
                Intl Journal of Cancer
                Wiley
                0020-7136
                1097-0215
                July 2023
                March 27 2023
                July 2023
                : 153
                : 1
                : 54-63
                Affiliations
                [1 ] Department of Public Health, Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
                [2 ] Department of Epidemiology Zhejiang Chinese Medical University School of Public Health Hangzhou China
                [3 ] Shanghai Municipal Center for Disease Control &amp; Prevention Shanghai China
                [4 ] Jiashan Institute of Cancer Prevention and Treatment Jiashan China
                [5 ] Department of Public Health, Fourth Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
                [6 ] Department of Public Health National Clinical Research Center for Child Health of Children's Hospital Zhejiang University School of Medicine Hangzhou China
                Article
                10.1002/ijc.34503
                36897046
                a69894d3-7504-4fac-b90e-32ce59cf6ec7
                © 2023

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                History

                Comments

                Comment on this article

                scite_

                Similar content249

                Cited by3

                Most referenced authors1,027